Premium Nahrungsergänzungsmittel | artgerecht

Oral Antidiabetic Drug – Mechanism and Use

Oral antidiabetic drugs are medications taken by mouth to treat type 2 diabetes. They lower blood sugar levels through various mechanisms and are often combined with lifestyle changes.

Regular tips about health Regular tips about health

Things worth knowing about "Oral Antidiabetic Drug"

Oral antidiabetic drugs are medications taken by mouth to treat type 2 diabetes. They lower blood sugar levels through various mechanisms and are often combined with lifestyle changes.

What Are Oral Antidiabetic Drugs?

Oral antidiabetic drugs are blood sugar-lowering medications taken in the form of tablets or capsules. They are primarily used in the management of type 2 diabetes mellitus when dietary changes and physical activity alone are insufficient to control blood glucose levels. Unlike insulin, which requires injection, oral antidiabetics are simply swallowed and work through various mechanisms in the body.

Indication

Oral antidiabetic drugs are mainly prescribed for patients with type 2 diabetes. The goal of treatment is to keep the HbA1c level (long-term blood sugar marker) and fasting blood glucose within a healthy range, thereby preventing diabetic complications such as kidney damage, retinal damage, or nerve damage. In some cases, oral antidiabetics such as metformin may also be used in conditions like polycystic ovary syndrome (PCOS).

Mechanism of Action

Depending on the drug class, oral antidiabetics act at different points in the body:

Biguanides (e.g., metformin): Reduce glucose production in the liver and improve the sensitivity of cells to insulin. Metformin is considered the first-line treatment for type 2 diabetes.
Sulfonylureas (e.g., glibenclamide, glimepiride): Stimulate the pancreas to produce more insulin.
DPP-4 inhibitors (gliptins, e.g., sitagliptin): Slow the breakdown of incretin hormones that promote insulin release after meals.
SGLT-2 inhibitors (gliflozins, e.g., empagliflozin, dapagliflozin): Promote the excretion of glucose through the kidneys, thereby lowering blood sugar. They also have proven cardiovascular and renal benefits.
GLP-1 receptor agonists (oral, e.g., oral semaglutide): Mimic the incretin hormone GLP-1, stimulating insulin release and reducing appetite.
Alpha-glucosidase inhibitors (e.g., acarbose): Slow the absorption of carbohydrates in the intestine.
Thiazolidinediones (glitazones, e.g., pioglitazone): Improve the sensitivity of body tissues to insulin.

Dosage

The dosage of oral antidiabetic drugs depends on the specific drug class, the individual blood glucose profile of the patient, and any existing comorbidities. Depending on the preparation, tablets are taken once or several times daily, sometimes with meals and sometimes independently. The exact dosage is always determined and regularly reviewed by the treating physician.

Side Effects

Oral antidiabetic drugs can cause different side effects depending on the drug class:

Metformin: Commonly gastrointestinal complaints (nausea, diarrhea); rarely lactic acidosis.
Sulfonylureas: Risk of hypoglycemia (low blood sugar) and weight gain.
DPP-4 inhibitors: Generally well tolerated; rarely upper respiratory tract infections.
SGLT-2 inhibitors: Increased risk of urinary tract and genital infections; risk of diabetic ketoacidosis if used incorrectly.
Alpha-glucosidase inhibitors: Flatulence and gastrointestinal discomfort are common.
Thiazolidinediones: Weight gain, fluid retention, increased fracture risk.

Treatment Context

Oral antidiabetic drugs are generally used as part of a comprehensive treatment plan that also includes dietary modification, regular physical activity, and regular medical check-ups. If a single medication is insufficient, several oral antidiabetics can be combined or supplemented with insulin. The choice of the appropriate medication is guided by the individual risk profile, existing comorbidities (e.g., heart failure, kidney disease), and the preferences of the patient.

References

American Diabetes Association: Standards of Medical Care in Diabetes. Diabetes Care, 2024.
Inzucchi SE et al.: Management of Hyperglycemia in Type 2 Diabetes. Diabetes Care, 2015.
World Health Organization (WHO): Classification of Diabetes Mellitus. Geneva, 2019.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.